TrialDiabetologia2016

Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial.

Stephen E Gitelman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.